...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Corp. Commences Operations

BDAZ

Yes, most of the second paragraph that you quoted me on is my own (optimistic) thinking. I'm pretty sure that the $300M was talked about, however. The $1B is if similar licensing deals are done in other regions and the planets align and there is peace on earth (all possible but a lot of things need to happen to make it come true).

In general, though, it was optimism and long term being talked about at that point.

I think we'll get some more clarification at the AGM.

masila

Share
New Message
Please login to post a reply